Back to top
more

CryoCell International (CCEL)

(Delayed Data from AMEX)

$6.20 USD

6.20
1,205

-0.29 (-4.47%)

Updated Aug 30, 2024 11:35 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 32% (171 out of 250)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Fiscal Year End for CryoCell International Inc falls in the month of November.

All items in Millions except Per Share data.

11/30/2023 11/30/2022 11/30/2021 11/30/2020 11/30/2019
Assets          
Cash & Equivalents 1 2 8 10 7
Receivables 7 6 5 6 6
Notes Receivable 0 0 0 0 0
Inventories 1 1 1 1 1
Other Current Assets 1 1 1 1 1
Total Current Assets 9 10 16 19 15
Net Property & Equipment 21 14 3 2 2
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 5 9 10 11 13
Deferred Charges 20 14 12 10 9
Intangibles 3 17 18 3 3
Deposits & Other Assets 1 1 1 1 0
Total Assets 61 65 61 46 43
Liabilities & Shareholders Equity 11/30/2023 11/30/2022 11/30/2021 11/30/2020 11/30/2019
Notes Payable 0 0 2 3 3
Accounts Payable 3 2 1 1 1
Current Portion Long-Term Debt 1 2 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 5 4 3 3 2
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 11 12 14 9 9
Total Current Liabilities 21 19 21 16 15
Mortgages 0 0 0 0 0
Deferred Taxes/Income 41 36 31 27 24
Convertible Debt 0 0 0 0 0
Long-Term Debt 8 9 0 3 6
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 1 2 4 2 5
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 72 66 56 49 50
Shareholders Equity 11/30/2023 11/30/2022 11/30/2021 11/30/2020 11/30/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 43 43 42 37 36
Retained Earnings -31 -22 -17 -19 -22
Other Equity 0 0 0 0 0
Treasury Stock 23 23 21 21 21
Total Shareholder's Equity -11 -2 4 -3 -7
Total Liabilities & Shareholder's Equity 61 65 61 46 43
Total Common Equity -11 -2 4 -3 -7
Shares Outstanding 8.20 8.50 8.50 7.50 7.80
Book Value Per Share -1.35 -0.18 0.49 -0.36 -0.89

Fiscal Year End for CryoCell International Inc falls in the month of November.

All items in Millions except Per Share data.

5/31/2024 2/29/2024 11/30/2023 8/31/2023 5/31/2023
Assets          
Cash & Equivalents 2 1 1 1 2
Receivables 7 7 7 6 7
Notes Receivable 0 0 0 0 0
Inventories 1 1 1 1 1
Other Current Assets 1 1 1 1 1
Total Current Assets 10 9 9 10 10
Net Property & Equipment 22 22 21 19 17
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 5 5 5 9 9
Deferred Charges 20 20 20 14 14
Intangibles 3 3 3 16 17
Deposits & Other Assets 1 1 1 1 1
Total Assets 63 62 61 70 69
Liabilities & Shareholders Equity 5/31/2024 2/29/2024 11/30/2023 8/31/2023 5/31/2023
Notes Payable 0 0 0 0 0
Accounts Payable 2 3 3 3 4
Current Portion Long-Term Debt 4 2 1 3 2
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 3 4 5 2 2
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 10 10 11 11 11
Total Current Liabilities 19 19 21 19 20
Mortgages 0 0 0 0 0
Deferred Taxes/Income 44 43 41 40 39
Convertible Debt 0 0 0 0 0
Long-Term Debt 8 8 8 8 9
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 1 1 2 2
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 73 72 72 70 70
Shareholders Equity 5/31/2024 2/29/2024 11/30/2023 8/31/2023 5/31/2023
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 44 44 43 43 43
Retained Earnings -30 -31 -31 -20 -21
Other Equity 0 0 0 0 0
Treasury Stock 25 24 23 23 23
Total Shareholder's Equity -11 -10 -11 0 -1
Total Liabilities & Shareholder's Equity 63 62 61 70 69
Total Common Equity -11 -10 -11 0 -1
Shares Outstanding 8.10 8.20 8.20 8.20 8.30
Book Value Per Share -1.33 -1.26 -1.35 0.00 -0.10